In this episode of the Alumni Ventures' Tech Optimist podcast, join Mike Collins and Managing Partner Matt Caspari as they delve into three transformative breakthroughs reshaping our approach to public safety, material science, and healthcare. The episode kicks off with an in-depth look at ZeroEyes, an AI solution designed to prevent mass shootings by analyzing surveillance footage to identify potential threats before they escalate. Next, the conversation shifts to a novel method in quantum material research, where scientists are innovating material properties at the atomic level to pave the way for future technological advancements. The discussion concludes with an exploration of CAR T-cell therapy's latest developments, highlighting its potential to treat tough cancers like glioblastoma through personalized immune system enhancements. Tune in to discover how these pioneering technologies are setting new standards in their respective fields and promising a safer, healthier future.

To Learn More:

• Alumni Ventures (AV)
• AV LinkedIn
• AV Deep Tech Fund
• Tech Optimist

Speakers:

• Mike Collins - Host 
• Matt Caspari - Guest 

Chapters:

• (00:00) - Intro

Legal Disclosure:

• https://av-funds.com/tech-optimist-disclosures